{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:05:39Z","timestamp":1786979139288,"version":"build-2736575974"},"publisher-location":"Vienna","reference-count":36,"publisher":"Springer Vienna","isbn-type":[{"value":"9783211831144","type":"print"},{"value":"9783709164679","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998]]},"DOI":"10.1007\/978-3-7091-6467-9_18","type":"book-chapter","created":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T21:23:41Z","timestamp":1349472221000},"page":"199-207","source":"Crossref","is-referenced-by-count":14,"title":["Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer\u2019s disease"],"prefix":"10.1007","author":[{"given":"J.","family":"Poirier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"S\u00e9vigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"18_CR1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1523\/JNEUROSCI.17-02-00516.1997","volume":"17","author":"T Arendt","year":"1997","unstructured":"Arendt T, Schindler C, Bruckner M, Eschrich K, Bigl V, Zedlick D, Markova L (1997) Plastic neuronal remodeling is impaired in patients with Alzheimer\u2019s disease carrying apolipoprotein \u025b4 allele. J Neurosci 17: 516\u2013529","journal-title":"J Neurosci"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1471-4159.1992.tb09752.x","volume":"58","author":"I Aubert","year":"1992","unstructured":"Aubert I, Araujo DM, C\u00e9cyre D, Robitaille Y, Quirion R (1992) Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer\u2019s and Parkinson\u2019s diseases. J Neurochem 58: 529\u2013541","journal-title":"J Neurochem"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0169-328X(95)00097-C","volume":"33","author":"P Bertrand","year":"1995","unstructured":"Bertrand P, Oda T, Finch CE, Pasinetti GM, Poirier J (1995) Association between apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer\u2019s disease. Mol Brain Res 33: 174\u2013178","journal-title":"Mol Brain Res"},{"key":"18_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1749-6632.1996.tb34415.x","volume":"777","author":"U Beffert","year":"1996","unstructured":"Beffert U, Poirier J (1996) Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer\u2019s disease. Ann NY Acad Sci 777: 166\u2013174","journal-title":"Ann NY Acad Sci"},{"key":"18_CR5","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1172\/JCI113943","volume":"83","author":"JK Boyles","year":"1989","unstructured":"Boyles JK, Zoellner CD, Anderson LJ, Kosick LM, Pitas RE, Weisgraber KH, Hui DY, Mahley RW, Gebicke-Haeter PJ, Ignatius MJ, Shooter EM (1989) A role for apolipoprotein E, apolipoprotein A-1, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83: 1015\u20131031","journal-title":"J Clin Invest"},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 and risk of Alzheimer\u2019s disease in late onset families. Science 261: 921\u2013923","journal-title":"Science"},{"key":"18_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.ATV.8.1.1","volume":"8","author":"J Davignon","year":"1988","unstructured":"Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1\u201321","journal-title":"Arteriosclerosis"},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","volume":"ii","author":"P Davies","year":"1976","unstructured":"Davies P, Maloney AJR (1976) Selective loss of central cholinergic neurons in Alzheimer\u2019s disease. Lancet ii: 1403","journal-title":"Lancet"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0304-3940(89)90689-7","volume":"100","author":"RM Dowson","year":"1989","unstructured":"Dowson RM (1989) Tacrine slows the rate of ageing of sarin-inhibited acetylcholine esterase. Neurosci Lett 100: 227\u2013230","journal-title":"Neurosci Lett"},{"key":"18_CR10","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"L Farrer","year":"1997","unstructured":"Farrer L and the Apo E and Alzheimer\u2019s disease meta-analysis consortium (1997) Effect of age, gender and ethnicity on the association of apolipoprotein E genotype and Alzheimer\u2019s disease. JAMA 278: 1349\u20131356","journal-title":"JAMA"},{"key":"18_CR11","first-page":"384","volume-title":"Research advances in Alzheimer\u2019s disease and related disorders","author":"D Guillaume","year":"1995","unstructured":"Guillaume D, Dea D, Davignon J, Poirier J (1995) Low density lipoprotein pathways in the central nervous system and apolipoprotein E isoform-specific differences. In: Iqbal K, Mortimer JA, Winblad B, Winiewski H (eds) Research advances in Alzheimer\u2019s disease and related disorders. Wiley, New York, pp 384\u2013395"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.6474172","volume":"225","author":"BT Hyman","year":"1984","unstructured":"Hyman BT, Van Hoesen GW, Damasion AR, Barnes CL (1984) Alzheimer\u2019s disease: cell-specific pathology isolates the hippocampal formation. Science 225: 1168\u20131170","journal-title":"Science"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/jama.1994.03510370037029","volume":"271","author":"MJ Knapp","year":"1994","unstructured":"Knapp MJ, Knopman DS, Solomon DR (1994) A 30-week randomized controlled clinical trials of high doses of tacrine in patients with Alzheimer\u2019s disease. JAMA 271: 985\u2013991","journal-title":"JAMA"},{"key":"18_CR14","first-page":"405","volume-title":"Research advances in Alzheimer\u2019s disease and related disorders","author":"E Masliah","year":"1995","unstructured":"Masliah E, Mallory M, Alford M, Mucke L (1995a) Abnormal synaptic regeneration in APP695 transgenic and apoE knockout mice. In: Iqbal K, Mortimer JA, Windblad B, Wisniewski HM (eds) Research advances in Alzheimer\u2019s disease and related disorders Wiley, New York, pp 405\u2013414"},{"key":"18_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1006\/exnr.1995.1088","volume":"136","author":"E Masliah","year":"1995","unstructured":"Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD (1995b) Neurode-generation in the central nervous system of apoE-deficient mice. Exp Neurol 136: 107\u2013122","journal-title":"Exp Neurol"},{"key":"18_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y, Tomonaga M, Kawasaki H (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and in Creutzfeld-Jacob disease. Brain Res 541: 163\u2013166","journal-title":"Brain Res"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1073\/pnas.89.5.1671","volume":"89","author":"RM Nitsch","year":"1992","unstructured":"Nitsch RM, Blusztajn JK, Pitas AG, Slack BE, Wurtman RJ (1992) Evidence for a membrane defect in Alzheimer\u2019s disease. Proc Natl Acad Sci 89: 1671\u20131675","journal-title":"Proc Natl Acad Sci"},{"key":"18_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0140-6736(93)91728-5","volume":"342","author":"S Noguchi","year":"1993","unstructured":"Noguchi S, Murakami K, Yamada N (1993) Apolipoprotein E and Alzheimer\u2019s disease. Lancet 342: 737","journal-title":"Lancet"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/0140-6736(93)91729-6","volume":"342","author":"H Payami","year":"1993","unstructured":"Payami H, Kaye J, Heston LL, Schellenberg GD (1993) Apolipoprotein E and Alzheimer\u2019s disease. Lancet (letter) 342: 738","journal-title":"Lancet (letter)"},{"key":"18_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0022-510X(77)90073-9","volume":"34","author":"EK Perry","year":"1977","unstructured":"Perry EK, Gibson PH, Blessed G (1977) Neurotransmitter enzyme abnormalities in senile dementia. J Neurol Sci 34: 247\u2013265","journal-title":"J Neurol Sci"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0166-2236(94)90156-2","volume":"12","author":"J Poirier","year":"1994","unstructured":"Poirier J (1994) Apolipoprotein E in animal models of brain injury and in Alzheimer\u2019s disease. Trends Neurosci 12: 525\u2013530","journal-title":"Trends Neurosci"},{"key":"18_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0169-328X(91)90002-F","volume":"9","author":"J Poirier","year":"1991","unstructured":"Poirier J, Hess M, May PC, Finch CE (1991) Cloning of hippocampal poly(A+) RNA sequences that increase after entorhinal cortex lesion in adult rat. Mol Brain Res 9: 191\u2013195","journal-title":"Mol Brain Res"},{"key":"18_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0169-328X(91)90111-A","volume":"11","author":"J Poirier","year":"1991","unstructured":"Poirier J, Hess M, May PC, Finch CE (1991a) Apolipoprotein E-and GFAP-RNA in hippocampus during reactive synaptogenesis and terminal proliferation. Mol Brain Res 11: 97\u2013106","journal-title":"Mol Brain Res"},{"key":"18_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0306-4522(93)90456-P","volume":"55","author":"J Poirier","year":"1993","unstructured":"Poirier J, Baccichet A, Dea D, Gauthier S (1993) Role of hippocampal cholesterol synthesis and uptake during reactive synaptogenesis in adult rats. Neuroscience 55: 81\u201390","journal-title":"Neuroscience"},{"key":"18_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","volume":"342","author":"J Poirier","year":"1993","unstructured":"Poirier J, Davignon J, Bouthillier D, Bertrand P, Gauthier S (1993a) ApolipoproteinE and Alzheimer\u2019s disease. Lancet 342: 697\u2013699","journal-title":"Lancet"},{"key":"18_CR26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/978-1-4615-8149-9_12","volume-title":"Alzheimer\u2019s disease: therapeutic strategies","author":"J Poirier","year":"1994","unstructured":"Poirier J, Aubert I, Bertrand P, Quirion R, Gauthier S, Nalbantoglu J (1994) Apolipoprotein E4 and cholinergic dysfunction in AD: A role for the amyloid\/apoE4 complex? In: Giacobini E, Becker RE (eds) Alzheimer\u2019s disease: therapeutic strategies. Birkh\u00e4user, Boston, pp 72\u201376"},{"key":"18_CR27","doi-asserted-by":"publisher","first-page":"12260","DOI":"10.1073\/pnas.92.26.12260","volume":"92","author":"J Poirier","year":"1995","unstructured":"Poirier J, Aubert I, Quirion R, Farlow M, Nalbantoglu J, Gilfix BG, Gauhier S (1995) Apolipoprotein \u025b4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer\u2019s disease. Proc Natl Acad Sci 92: 12260\u201312264","journal-title":"Proc Natl Acad Sci"},{"key":"18_CR28","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","volume":"257","author":"SC Rall","year":"1982","unstructured":"Rall SC, Weisgraber KH, Mahley RW (1982) Abnormal lipoprotein receptor binding activity of the human apoE due to arginine-cysteine interchange at a single site. J Biol Chem 257: 4171\u20134178","journal-title":"J Biol Chem"},{"key":"18_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(97)80089-X","volume":"349","author":"F Richard","year":"1997","unstructured":"Richard F, Hetbecque N, Neuman E, Guez E, Levy R, Amouyel P (1997) ApoE genotyping and response to drug treatment in Alzheimer s disease. Lancet 349: 539\u2013540","journal-title":"Lancet"},{"key":"18_CR30","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BA, Gusella JF, McClaclans DR, Alberts MJ, Roses AD (1993) Association of apolipoprotein E allele E4 with late onset familial and sporadic Alzheimer\u2019s disease. Neurology 43: 1467\u20131472","journal-title":"Neurology"},{"key":"18_CR31","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"D Schmechel","year":"1993","unstructured":"Schmechel D, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Roses AD (1993) Increased amyloid \u03b2-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer\u2019s disease. Proc Natl Acad Sci 90: 9649\u20139653","journal-title":"Proc Natl Acad Sci"},{"key":"18_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0304-3940(95)11343-6","volume":"187","author":"K Soininen","year":"1995","unstructured":"Soininen K, Kosunen O, Helisalmi S, Mannermaa A, Riekkinen P (1995) A severe loss of choline acetylcholine transferase in the frontal cortex of Alzheimer\u2019s disease patients carrying apolipoprotein E4 allele. Neurosci Lett 187: 79\u201382","journal-title":"Neurosci Lett"},{"key":"18_CR33","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid \u03b2-peptide: isoform-specific effect and implication for late onset Alzheimer\u2019s disease. Proc Natl Acad Sci 90: 8098\u20138102","journal-title":"Proc Natl Acad Sci"},{"key":"18_CR34","first-page":"29","volume-title":"Acetylcholine synthesis in neurons","author":"S Tucek","year":"1978","unstructured":"Tucek S (1978) Choline acetyltransferase. In: Acetylcholine synthesis in neurons. Chapman and Hall, London, pp 29\u201342"},{"key":"18_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1399-0004.1979.tb02027.x","volume":"15","author":"G Utermann","year":"1979","unstructured":"Utermann G, Pruin N, Steinmetz A (1979) Apolipoprotein E polymorphism in health and disease. Clin Genet 15: 37\u201362","journal-title":"Clin Genet"},{"key":"18_CR36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1021\/bi00507a059","volume":"20","author":"VI Zannis","year":"1981","unstructured":"Zannis VI, Breslow JL (1981) Human VLDL-apoE isoprotein polymorphism is explained by genetic variation and post-translational modifications. Biochemistry 20: 1033\u20131041","journal-title":"Biochemistry"}],"container-title":["Journal of Neural Transmission. Supplementa","Ageing and Dementia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7091-6467-9_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T20:25:05Z","timestamp":1643487905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-7091-6467-9_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"ISBN":["9783211831144","9783709164679"],"references-count":36,"URL":"https:\/\/doi.org\/10.1007\/978-3-7091-6467-9_18","relation":{},"ISSN":["0303-6995"],"issn-type":[{"value":"0303-6995","type":"print"}],"subject":[],"published":{"date-parts":[[1998]]}}}